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Objective. To investigate feasibility of multiport and laparoendoscopic single-site (LESS) nonischemic laparoscopic partial
nephrectomy (NI-LPN) utilizing bipolar radiofrequency coagulator. Methods. Multicenter retrospective review of 60 patients
(46 multiport/14 LESS) undergoing NI-LPN between 4/2006 and 9/2009. Multiport and LESS NI-LPN utilized Habib 4X
bipolar radiofrequency coagulator to form a hemostatic zone followed by nonischemic tumor excision and renorrhaphy.
Demographics, tumor/perioperative characteristics, and outcomes were analyzed. Results. 59/60 (98.3%) successfully underwent
NI-LPN. Mean tumor size was 2.35cm. Mean operative time was 160.0 minutes. Mean estimated blood loss was 131.4mL.
Preoperative/postoperative creatinine (mg/dL) was 1.02/1.07 (P = .471). All had negative margins. 12 (20%) patients developed
complications.3(5%)developed urineleaks.Nodiﬀerences between multiportandLESS-PNwere notedasregards demographics,
tumor size, outcomes, and complications. Conclusion. Initial experience demonstrates that nonischemic multiport and LESS-PN
is safe and eﬃcacious, with excellent short-term preservation of renal function. Long-term data are needed to conﬁrm oncological
eﬃcacy.
1.Introduction
In 2009, there were approximately 57,760 new cases of
kidney cancer with 12,980 deaths in the United States [1].
Increasing incidence of small renal masses (SRMs) [2], along
with an increased awareness of the metabolic consequences
of removal of normally functioning renal tissue by radical
nephrectomy [3–7], has led to a paradigm shift of surgical
management with greater emphasis on nephron sparing and
minimally invasive approaches [8, 9]. While laparoscopic
partialnephrectomy (LPN)isbecomingrecognized asastan-
dardformanagement ofSRM,concernsregarding prolonged
warm ischemia times continue to forestall its widespread
adoption [8, 9].
By combining working trocar sites and the eventual ex-
traction site into a single location, laparoendoscopic single-
site (LESS) surgery further limits the invasiveness of lap-
aroscopy and may enhance advantages associated with tra-
ditional laparoscopy. Reduced incisional morbidity and im-
proved cosmesis have largely sparked a growing interest
in the utilization of this technique to perform upper tract
urologic surgery [10–13]. Recent reports have demonstrated
the feasibility of LESS partial nephrectomy [12, 13].
The Habib4X(Angiodynamics, Queensbury, NY)isa bi-
polar radiofrequency coagulation device which has been
used for nonischemic resections of the liver [14]a sw e l la s
kidney[15].Weinvestigatedthefeasibility,eﬃcacy,andrenal2 Diagnostic and Therapeutic Endoscopy
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Figure 1: Laparoscopic Habib 4X (Angiodynamics, Queensbury,
NY).
functional outcomes of multiport and LESS nonischemic
LPN utilizing the laparoscopic Habib 4X.
2.PatientsandMethods
Multicenter retrospective review of 60 patients (31M/29F,
mean age of 57.9 years) who underwent nonischemic (NI-)
LPN between 4/2006 and 9/2009. Mean followup was 16.3 ±
10.5 months. Institutions (performing surgeons) were as fol-
lows: University of California San Diego (IHD), Johns
Hopkins University (MEA), and University of Florida (SP).
Selection criteria were patients with contrast-enhancing
small renal masses that would be technically amenable for
multiport or LESS partial nephrectomy (PN).
2.1. Surgical Technique Multiport LPN. All procedures were
performed by transperitoneal laparoscopic or retroperito-
neoscopicapproaches [16]. Brieﬂy,after obtaining transperi-
toneal or retroperitoneoscopic access, the kidney was mobi-
lized following ureteral identiﬁcation. Hilar control was ob-
tained, and the vessels were prepared for possible ischemic
occlusion if the need arose. The kidney was then defatted to
expose the tumoror region of the tumor. The tumor was cir-
cumscribed with at least a 1.0cm margin utilizing the Habib
4X (Figure 1) to create a zone of hemostasis (Figure 2(a)).
The Habib 4X utilizes the RITA 1500X generator which
operates at 480KHz with a 125W power that has 4 tines
(3cm in length and 1cm apart) with 2 planes of coagulation
createdbyeach2tines.Thedepthofcoagulationiscontrolled
by the depth of insertion, and the duration of coagulation
is controlled by the surgeon with on-demand repeat. The
duration is gradually decreased because of the rise in tissue
impedance from charring. We typically use a 50W setting
but that is usually dropped to 25W for larger vessels to allow
for longer duration of coagulation. Parenchymal bleeding
is encountered when the tines are removed and that is
controlled by reinsertion over the site of bleeding.
After the tumoris clearly demarcated by a zone ofcoagu-
lation, it is excised by cold EndoShears(Covidien, Mansﬁeld,
Mass) (Figure 2(b)). Standard sutured renorrhaphy (Fig-
ure 2(c)) was then performed with sutured collecting system
closure, and FloSeal (Baxter, Deerﬁeld, Ill) was utilized as
a hemostatic adjunct, and the parenchymal defect was closed
over an oxidized cellulose mesh bolster with interrupted
sutures using LapraTy absorbable clips (Ethicon, Cincinnati,
Ohaio) [17]( F i g u r e2(d)). Specimens were intraoperatively
evaluated by a pathologist for margin status (Figure 3).
A Jackson-Pratt drain was placed to monitor for delayed
bleed or leaks.
2.2. Surgical Technique for Nonischemic LESS-PN. After gen-
eral anesthesia, the patient is placed in a modiﬁed ﬂank posi-
tion (with the patient at a 30-degree angle with the kidney
rest up and the table ﬂexed). A 3-4cm periumbilical incision
is made and carried down to the anterior abdominal wall
fascia. A 5mm extra long (150mm length) Xcel trocar
(Ethicon-Endosurgery, Cincinnati, Ohaio) is then inserted
at the most cranial aspect of this incision, at the junction
of the umbilicus with the fascia; pneumoperitoneum to
15mmHg is obtained, and a 5mm zero-degree 35cm long
laparoscope(Strkyer,Kalamazoo,Mich)isinserted toinspect
the abdomen; subsequently, a 65mm long, nonshielded low
proﬁle (65mm length) trocar (Ethicon) is inserted under
direct vision at a position of 1.0–1.5cm caudad to the initial
port,followedbytheinsertionofastandardlength(100mm)
12mm Xcel trocar (Ethicon) at the most caudal aspect of the
incision; another 1.0–1.5cm caudad to the prior low proﬁle
port. We minimized the intracorporeal proﬁle of the Xcel
trocars, and that in conjunction with the variety of trocar
lengths allowed us to stagger the external proﬁles in order
to minimize instrument clashing (Figure 4).
Tissuedissectionislargelyperformedwithstandardextra
long laparoscopic instruments (nonlocking laparoscopic
deBakey bowel forceps, right angle dissector, Maryland dis-
sector, endoshears) and 5mm harmonic ACE 36cm curved
shears (Ethicon). Utilization of extra-long instruments cre-
ates extracorporeal triangulation which compensates for the
intracorporeal triangulation aﬀorded by spaced trocars in
multisite laparoscopy. Following the takedown of the white
line of Toldt, the 0-degree laparoscope is exchanged for
a 5mm, 45cm, 30-degree laparoscope with a right angle
adaptor and inline camera head (Strkyer).
Initial surgical steps including colonic mobilization,
ureteral identiﬁcation, and vascular dissection are identical
to multiport LPN. The standard techniques of LPN are reca-
pitulated with few modiﬁcations [16]. The Habib 4X then
was utilized to achieve a zone of parenchymal hemostasis in
the absence of ischemic renal conditions prior to cold tumor
excision and renorrhaphy, as described above [15–17].
2.3. Postoperative Protocol. It consisted of ﬁrst night bed rest,
then rapid mobilization, and advancement of diet as tol-
erated with monitoring of renal function, urine, and drain
outputs. If no evidence of a leak was noted, the drain and
foley were discontinued prior to discharge. Outpatient fol-
lowup consisted of serial physical exams, serum chemistries
and hematology labs, and radiographic surveillance.
2.4. Data Analysis. We analyzed patient demographics (age,
gender, BMI, and race), operative outcomes (operative time,
estimated blood loss, and collecting system entry), patho-
logic outcomes (size, margin status, and ﬁnal pathology),Diagnostic and Therapeutic Endoscopy 3
(a) (b)
(c) (d)
Figure 2:(a)LaparoscopicHabib4Xcircumscribing leftkidneylowerpole tumor;(b) nonischemiccoldexcisionofrenaltumor;(c) sutured
renorrhaphy; and (d) FloSeal application for hemostasis.
Figure 3: Resected left lower pole inked margin demonstrated by
intraoperative pathology consult.
and complications (urologic and nonurologic). TNM stage
was deﬁned by the American Joint Committee on Can-
cer 2002 [18]. Renal function was determined by serum
creatinine (mg/dL) measurement and calculated estimated
glomerular ﬁltration rate (eGFR) using the MDRD formula
(eGFR (in mL per minute per 1.73m2) = 186 × sCr − 1.154
× age0.203× (0.742 if female) × (1.210 if black)) [19]. Means
were compared between the two groups (multiport and
LESS) using t-tests/ANOVA and ﬁsher’s exact test for con-
tinuous and categorical variables, respectively. All reported
P values were based on two-sided tests of signiﬁcance, with
P<. 05 considered to indicate statistical signiﬁcance.
3.Results
59/60 (98.3%) patients successfully underwent nonischemic
LPN and LESS-PN.One patient,anattempted LESS-PNona
patient with a posterior left upper pole mass, was converted
to open nonischemic PN due to dense upper pole adhesions
and nonprogression due to a prior history of multiple intra-
abdominal procedures and radiation. There were no con-
versions to ischemic partial nephrectomy, open surgery, or
radical nephrectomy.
Table 1 demonstrates demographics and tumor charac-
teristics. Mean followup was 16.3 ± 10.5m o n t h sa n dw a s
signiﬁcantly longer for multiport LPN (18.8 ±10.8) than for
LESS-PN(9.4±2.6,P = .004).Meanagewas57.9±12.7years.
31 (51.7%) were male, and 29 (48.3%) were female. Mean
BMI was 28.4 ± 0.5kg/m 2. 66.7% (40) were Caucasian and
33.3% (20) were other. Mean tumor size was 2.35 ± 1.30cm.
No signiﬁcant diﬀerencewas found between MPL and LESS-
PN groups with respect to age, gender/race distribution,
BMI, or tumor size.4 Diagnostic and Therapeutic Endoscopy
Table 1: Patient demographics and tumor characteristics.
Total
N = 60
Multiport LPN
N = 46
LESS-PN
N = 14 P value
Mean f/u (months) 16.3 ±10.51 8 .8 ±10.89 .4 ±2.6 .004
Mean age (yrs.) 57.9 ±12.75 7 .4 ±13.35 9 .3±11.7 .627
Gender .547
Male 31 (51.7%) 25 (54.3%) 6 (42.9%)
Female 29 (48.3%) 21 (46.7%) 8 (57.1%)
Mean BMI (Kg/m2)2 8 .4 ±0.52 8 .0 ±4.82 8 .7 ±5.5 .737
Race/Ethnicity .195
Caucasian 40 (66.7%) 33 (71.6%) 7 (50%)
Other 20 (33.3%) 13 (28.3%) 7 (50%)
Laterality .770
Right 28 (46.7%) 22 (47.8%) 6 (42.9%)
Left 32 (52.3%) 24 (52.2%) 8 (57.1%)
Tumor location .043
Upper pole 13 (21.7%) 10 (21.8%) 3 (21.4%)
Mid-pole 20 (33.3%) 14 (30.4%) 6 (42.9%)
Lower pole 27 (45.0%) 22 (47.8%) 5 (35.7%)
Tumor location .241
Anterior 34 (56.7%) 25 (54.3%) 9 (64.3%)
Posterior 25 (41.7%) 20 (43.5%) 5 (35.7%)
Central 1 (1.6%) 1 (2.2%) 0 (0%)
Tumor size (cm) 2.35 ±1.30 2.47 ±1.38 1.95±0.92 .189
Table 2: Perioperative parameters, outcomes, and complications.
Total
N = 60
Multiport LPN
N = 46
LESS-PN
N = 14 P value
Mean OR time (min) 164.0 ±48.8 159.9 ±52.1 177.4 ±34.0 .242
Mean EBL (mL) 131.4 ±98.1 126.6 ±94.7 148.1 ± 112 .491
Collecting system entry 17 (28.3%) 11 (23.9%) 6 (42.9%) .190
LOS (days) 2.60 ±1.17 2.61 ±1.23 2.57 ±0.94 .917
Preoperative serum creatinine (mg/dL) 1.02 ±0.41 1.06 ±0.43 0.89 ±0.33 .187
Postoperative serum creatinine (mg/dL) 1.07 ±0.45 1.10 ±0.47 0.97 ±0.35 .340
Preoperative eGFR (mL/min/1.73m2)8 1 .4 ±26.97 9 .4 ±27.28 8 .1 ±26.0 .293
Postoperative eGFR (mL/min/1.73m2)7 7 .7 ±29.67 7 .4 ±31.07 8 .5 ±25.1 .905
Final pathology .759
RCC 34 (56.7%) 27 (58.7%) 7 (50%)
Benign histology 26 (43.3%) 19 (41.3%) 7 (50%)
Negative margins 60 (100%) 46 (100%) 14 (100%) 1.000
Complications 12 (20%) 9 (10.5%) 3 (21.4%) 1.000
Urine leak 3 (5%) 2 (4.3%) 1 (7.1%) .556
Table 2 shows perioperative parameters, outcomes, and
complications. Mean operative time was 164.0 ± 48.8m i n -
utes, and mean estimated blood loss was 131.4 ± 98.1mL.
Collecting system entry was made in 17/60 (28.3%). Mean
hospital length of stay was 2.60 ± 1.17 days. Final pathology
was renal cell carcinoma in 34 (56.7%) and Benign histology
in 26 (43.3%) (oncocytoma (5), AML (13), other (8)). All
had negative surgicalmargins. Preoperativeserumcreatinine
(mg/dL) and creatinine at the time of last followup were
1.02 ± 0.41 and 1.07 ± 0.45 (P = .471). Preoperative eGFR
(mL/min/1.73m2) and eGFR at the time of the last followup
were 81.4 ± 26.9a n d7 7 .7 ± 29.6( P = .471). There were no
signiﬁcant diﬀerences between multiport and LESS-PN with
respect to mean operative time, EBL, collecting system entry,Diagnostic and Therapeutic Endoscopy 5
length of stay, preoperative/postoperative creatinine and
eGFR, and pathological distribution. At the last followup, all
patients were alive and disease-free.
There were 12 complications in 12 patients (20%) in our
series. 1 (1.7%) patient developed clot obstruction which
required stent placement on postoperative day 2. 3 (5%)
patients developed urine leaks which resolved with con-
servative management (two were early leaks managed with
Jackson-Pratt drain continuing for 1 and 2 weeks, respec-
tively. 1 patient developed a delayed urinary leak treated
with percutaneous drain placement). All leaks were resolved
with conservative management. 3 patients (5%) developed
postoperative ileus managed conservatively. 1 patient (1.7%)
developed each of the following: atrial ﬁbrillation, cystitis,
diverticulitis, pneumonia, and pneumothorax. 1 patient re-
ceived a platelet and blood transfusion, who had a history
of preoperative anemia and idiopathic thrombocytopenic
purpura. There were no signiﬁcant diﬀerences between the
groups with respect to complication and leak rates.
4.Discussion
By duplicating principles of open partial nephrectomy, lap-
aroscopicpartialnephrectomyhasdemonstratedequivalence
in oncological outcomes [8, 9, 23] while providing the bene-
ﬁts of minimally invasive surgery such as improvedcosmesis,
lowernarcoticrequirements,shorterhospitalstays,andmore
rapid return to normal activities [24, 25]. Adoption of lap-
aroscopic partial nephrectomy, however, continues to be
hampered by concerns regarding the achievement of reliable
hemostasis [26] and prolonged warm ischemia time and its
possible consequences as regards long-term renal function
[8, 9, 27, 28].
Interest in reducing or eliminating ischemic renal occlu-
sion has spurred the development of a variety of strate-
gies including sutureless renorrhaphy [29, 30], superselec-
tive embolization of segmental vessels [31], and energy-
based nonischemic renal resection utilizing laser [32, 33],
m i c r o w a v et i s s u ea b l a t i o n[ 34], and monopolar radiofre-
quency devices [35, 36]. Partial nephrectomy utilizing bipo-
lar radiofrequency device was ﬁrst investigated by Pareek
et al. [37] in a porcine model. In humans, Andonian et al.
[38] were the ﬁrst to report success in humans with renal
masses smaller than 2cm utilizing the Habib 4X. White
et al. [15] reported a randomized controlled trial utilizing
the Habib 4X in open partial nephrectomy versus ischemic
open partial nephrectomy, reporting a signiﬁcant decrease
in blood loss and operative time for tumors with mean size
of 3.3cm. Zeltser et al. [39] used the laparoscopic Habib 4X
in a porcine model with good results, and recently, Nadler
et al. [20] reported their clinical experience in 16 patients
who underwent a hybrid laparoscopic and robotic-assisted
laparoscopic partial nephrectomy with the Habib 4X. They
noted a median blood loss of 125mL, median operative time
of435minutes, mean hospitalstayof2.6days,andwith good
renal functional preservation (preoperative/postoperative
serum creatinine of 1.03/1.10). Importantly, all patients had
negative margins, and none were converted to ischemic or
open technique. Our multicenter experience, utilizing pure
(a)
(b)
Figure 4: (a) LESS platform, periumbilical incision for left partial
nephrectomy, demonstrating in cranial to caudal direction (left
to right): 5mm Extra-long Xcel trocar, 5mm short nonshielded
trocar, and 12mm Xcel trocar (with Habib 4X deployed through
the 12mm Trocar); (b) periumbilical incision 6-month status after
LESS-PN.
laparoscopy, demonstrates similar outcomes with respect to
estimated blood loss (131mL), hospital stay (2.60 days), and
preservation of renal function (preoperative/postoperative
serum creatinine 1.02/1.07, Table 2) to those achieved by
Nadler et al. [20] with decreased operative time (164 min-
utes) and with the cost savings of using a purely laparoscopic
platform [40].
Warm ischemia time is a major road blockin performing
laparoscopic partial nephrectomy [27]. Indeed, while reﬁne-
ment of technique and emerging reports on the feasibility
of robotically assisted laparoscopy for nephron sparing sur-
gery, concern continues regarding potentially longer warm
ischemia times for minimally invasive surgery. On the other
hand, concerns have been raised regarding energy-based
modalities and potential limitations with respect to the as-
sessment of margins status as well as eﬃcacy of collecting
system closure and reconstruction. By eliminating warm
ischemia and facilitating complexreconstructionwithrobot-
ically assisted laparoscopy, Nadler et al. [20]h a v ep o i n t e d
the way in expanding the range of utilization of nephron
sparing surgery. Indeed, our experience with 17/60 (28.3%
of patients/tumors, Table 2) collecting system entries and6 Diagnostic and Therapeutic Endoscopy
Table 3: Comparison of our data to reported world literature.
Our series Gill et al. [8]N a d l e r e t a l . [20] Celia et al. [21]C r e p e l e t a l . [22]
Number of patients 60 771 16 592 91
Mean age (yrs) 57.9 59.4 — — —
Tumor size (cm) 2.35 2.7 — 2.2 2.7
Hospital days 2.6 3.3 2.6 — 9.1
Operative time (min) 164.2 300 435 — 163
Estimated blood loss (mL) 131.4 201 125 — 363
Urine leak rate 5.0% 2.3% 0.0% 2.1% 12.1%
Positive margins 0% 0% 2%
Pre/Post op creatinine (mg/dL) 1.02/1.07 1.01/1.18 1.03/1.10 — —
sutured renorrhaphy (Figure 2) conﬁrms that the utilization
of nonischemic technique is ideally suited for a minimally
invasive surgery as elimination of ischemia time will not
only allay concerns about the prolongation of ischemia time
and its deleterious eﬀects, but also permit complex recon-
struction and therefore ultimately enhance the adoption of
minimally invasive nephron sparing surgery for a wider
varietyoftumors.Oururinaryleakrateof5%(3patients),all
of whom resolved with conservative measures, is consistent
with rates reported in large series of laparoscopic partial
nephrectomy [8, 20–22]. Furthermore, as demonstrated by
our results, adhering to a 1cm margin outside the tumor
permitted the Habib 4X, a four-pronged device (prongs are
set 8mm apart) with minimal lateral coagulation spread, to
achieve a zone of coagulation that was away from the tumor.
Indeed, our 0% negative pathologic margins bear this out
(Table 2).
Indeed, in addition to a comparable leak rate, our out-
comes as regards to blood loss, operative time, margin posi-
tivity, and renal functional preservation compare very favor-
ably with large published multicenter studies (Table 3)[ 8,
20–22]. These data demonstrate that nonischemic laparo-
scopic partial nephrectomy utilizing the Habib 4X is not
only feasible but has a similar safety proﬁle to established
techniques and does not compromise oncological outcomes
with respect to margin positivity.
LESS-PN allows for the extraction ofthe enhancing renal
lesion, a deﬁnitive histologic conﬁrmation with excellent
preservation of renal function in this series. In a recent pub-
lication, Kaouk and Goel utilized a nonischemic technique
to perform LESS-PN. After PN, these authors achieved
hemostasis using ABC, Surgicel and a variety of surgical
adhesives; however, due to inability to achieve adequate
hemostasis in one case, they had to convert to multiport
laparoscopy [12]. Our experience with 14 LESS-PN not only
conﬁrms the feasibility of this procedure, but in a well-
matched cohort (Table 1) demonstrates similar outcomes
(Table 2) to our multiport LPN group. Indeed, the Habib
4X, which easily ﬁts through the 12mm laparoscopic port,
was a key facilitator of the LESS-PN approach, by allowing
controlled excision of the mass through a precreated hemo-
static plane around the tumor, and therefore minimizing
instrument clashing and potential loss of hemostatic control
in a crucial portion of the case. Furthermore, by creating
a hemostatic ﬁeld, we were able to proceed with the renor-
rhaphy in a meticulous manner and be able to surmount
the limitations of the LESS platform (instrument clashing,
triangulation) in an environment without the pressure of
ischemic time. While further investigation and comparison
is necessary, this preliminary series demonstrates that LESS-
PN is safe and technically feasible method for performing
complex renal surgery while maintaining strict adherence
to oncologic principles. Our encouraging results are the
ﬁrst reported comparison between multiport and LESS-PN.
Further studies, in addition to a comparison of quality-of-
life outcomes, are necessary to delineate what, if any speciﬁc
advantages, may lie with the LESS approach.
Our data is limited by its retrospective nature, limited
numbers, and short-term follow-up. Nonetheless, we are en-
couraged by the preliminary ﬁndings of our experience. Fur-
ther prospective comparison with ischemic partial nephrec-
tomy with longer-term outcomes is requisite.
5.Conclusion
Initial experience demonstrates that nonischemic L-NSS uti-
lizing Habib 4X is safe and eﬃcacious, with excellent short-
term preservation of renal function. In addition to longer-
term followup, direct prospective comparison to ischemic
NSS is requisite to conﬁrm the renal functional preservation
and oncological eﬃcacy of this technique.
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